Otezla is a Kit in the Human Prescription Drug category. It is labeled and distributed by Amgen Inc. The primary component is .
| Product ID | 55513-485_10ac0969-71a1-4429-924e-f638d552f7b9 |
| NDC | 55513-485 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Otezla |
| Generic Name | Apremilast |
| Dosage Form | Kit |
| Marketing Start Date | 2020-02-26 |
| Marketing Category | NDA / NDA |
| Application Number | NDA205437 |
| Labeler Name | Amgen Inc |
| Active Ingredient Strength | 0 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2020-02-26 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA205437 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2020-02-26 |
| Marketing Category | NDA |
| Application Number | NDA205437 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2020-02-26 |
| SPL SET ID: | f6b1f516-4972-4d82-bced-113e47b41cc5 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 55513-137 | Otezla | apremilast |
| 55513-369 | Otezla | apremilast |
| 55513-485 | Otezla | apremilast |
| 59572-630 | OTEZLA | apremilast |
| 59572-631 | OTEZLA | apremilast |
| 59572-632 | OTEZLA | apremilast |
| 70518-3155 | Otezla | apremilast |
| 60219-1410 | APREMILAST | APREMILAST |
| 60219-1744 | APREMILAST | APREMILAST |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() OTEZLA 86109590 4598910 Live/Registered |
Celgene Corporation 2013-11-04 |
![]() OTEZLA 86093816 4598865 Live/Registered |
Celgene Corporation 2013-10-17 |
![]() OTEZLA 85705380 4331247 Live/Registered |
Celgene Corporation 2012-08-16 |